@sulekchat's TRT claims about Alex Eubank, fact-checked

What did @sulekchat actually say?

This clip covers fitness influencer Alex Eubank reviewing his testosterone replacement therapy results after about four to five months on protocol. He started at 200 mg of testosterone per week, got labs showing a total testosterone of roughly 1,500 ng/dL, decided that was too high, and dropped his dose to 160 mg per week. His most recent labs came back at 932 ng/dL. He frames 200 mg weekly as "the max dose you can get prescribed from a doctor" and says the general accepted natural range is 300 to 900 ng/dL, with TRT qualification typically starting around 350 ng/dL or below. His stated goal was to land at the upper end of the reference range, and he argues he achieved that.

Does the science back this up?

Partially, and the parts he gets wrong are worth paying attention to. His testosterone level targets are roughly in line with clinical guidance, but his framing of 200 mg per week as the maximum prescribable dose is not accurate as a universal rule, and his qualification threshold is slightly off.

The Endocrine Society's 2018 clinical practice guidelines define hypogonadism as a consistently low morning total testosterone, typically below 300 ng/dL, combined with symptoms. The American Urological Association similarly uses 300 ng/dL as a common threshold. Eubank's figure of "350 and 100" appears to be a garbled reference to the 350 ng/dL range some clinics use, which is not a consensus cutoff but does appear in some men's health clinic protocols.

On dosing, studies of TRT in hypogonadal men typically use 75 to 100 mg of testosterone cypionate or enanthate weekly to achieve mid-normal physiologic levels (Bhasin et al., 2010, Journal of Clinical Endocrinology and Metabolism). A 200 mg weekly dose in that context tends to produce supraphysiologic levels, which is exactly what happened to Eubank. His 1,500 ng/dL result at 200 mg/week is consistent with what the literature would predict.

What did they get wrong (or right)?

Credit where it is due: Eubank's decision to lower his dose after seeing supraphysiologic labs is the right call, and the process he describes, getting labs, adjusting, re-testing, is how responsible TRT monitoring is supposed to work. That part deserves recognition.

What he got wrong: "200 milligrams of tests a week" is not universally "the max dose you can get prescribed from a doctor." Some physicians prescribe higher doses in specific clinical contexts, and many TRT protocols stay well below 200 mg weekly precisely because supraphysiologic levels are the likely outcome at that dose for most men. Framing 200 mg as a standard ceiling is misleading.

His reference range claim is also slightly muddled. The 250 to 1,100 ng/dL range he mentions from his clinic is plausible. However, describing 300 to 900 ng/dL as the general "natural range" glosses over the fact that normal ranges vary significantly by lab, age, and assay methodology (Travison et al., 2017, Journal of Clinical Endocrinology and Metabolism). A 932 ng/dL result on exogenous testosterone is not the same physiologically as a natural 932 ng/dL, and that distinction never gets mentioned.

What should you actually know?

If you are considering TRT after watching content like this, the most important thing to understand is that a testosterone number on a lab report does not tell the whole story. Free testosterone, sex hormone binding globulin, hematocrit, estradiol, and LH/FSH levels all matter in a complete TRT workup. Focusing only on total testosterone, which is what this video does entirely, is an incomplete picture.

Supraphysiologic testosterone levels, anything consistently above 1,000 to 1,100 ng/dL on therapy, are associated with elevated hematocrit, cardiovascular risk signals, and suppression of endogenous production. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), the largest randomized trial of TRT in men with hypogonadism and cardiovascular risk factors, found no significant increase in major adverse cardiac events but did note increased rates of pulmonary embolism and atrial fibrillation at higher exposure levels. This is an active research area, not a settled one.

TRT from a telehealth or men's health clinic is not the same as a monitored endocrinology relationship. Asking what monitoring schedule, what labs, and how often are questions worth asking before starting any hormone protocol.